Paragon 28®, Inc. Acquires the Assets of Additive Orthopaedics

The Additive Orthopaedics acquisition includes FDA Approved, First in the World 3D-printed Patient Specific Talus Spacer for the Treatment of Avascular Necrosis (AVN) for Humanitarian Use

DENVERJune 1, 2021 /PRNewswire/ — Paragon 28, Inc., a market-leading orthopedic medical device company focused exclusively on the foot-and-ankle, today announced that the Company has acquired the product lines of Additive Orthopaedics (“Additive”).

The Additive 3D-printed Patient Specific Talus Spacer was approved on February 17, 2021 by the US Food and Drug Administration (“FDA”) and is the first and only patient-specific total talus replacement implant authorized for use in the United States. The FDA approved the implant as a humanitarian use device. It is designed to replace the talus, the bone in the ankle that connects the leg and foot. The Additive implant provides patients access to a novel, joint-sparing alternative to traditional ankle fusion therapies.

Also acquired as part of the transaction was Additive’s internally developed, proprietary pre-operative surgical planning application to assist in surgical planning.  The application is an end-to-end, fully integrated cloud-based communication tool that aligns surgeons and engineers to design patient specific surgical plans and implants, optimizing patient outcomes.

“The addition of the Additive Orthopaedics product portfolio and surgical planning capabilities provides Paragon 28 customers exclusive access to the only FDA-approved patient specific total talus replacement implant,” said Albert DaCosta, Co-Founder and Chief Executive Officer of Paragon 28. “The Additive acquisition also significantly accelerates the Company’s strategy to leverage smart tools, artificial intelligence and advanced technology to improve patient outcomes.”

About Paragon 28, Inc.

Paragon 28, Inc. exclusively serves the foot-and-ankle surgical community and is dedicated to enhancing patient outcomes by advancing the science and research behind innovative technologies. The addition of Additive Orthopaedics’ assets bolsters Paragon 28’s Precision Ankle Solutions product offering, which includes the APEX 3D™ Total Ankle Replacement System, Gorilla® Ankle Fracture Plating System, Silverback® Ankle Fusion Plating System, and Phantom™ TTC Fusion Nail Systems. With this comprehensive portfolio, Paragon 28 provides its customers innovative ankle solutions for trauma, arthritis, and limb salvage.

For more information, please visit www.paragon28.com.

Press Contact: Brendan Shook, EVP of Marketing and Medical Education, (bshook@paragon28.com)

SOURCE Paragon 28, Inc.

About Peter Coffaro 573 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the orthopedic industry. Recognized by MedReps.com as one of the top medical sales influencers in the industry; he has 10 years of combined sales management experience and has held positions as a Director, General Manager and Distributor. Peter has worked for some of the top orthopedic companies in the world - Zimmer, DePuy and Stryker. He is also the founder of OrthoFeed: a popular blog that covers orthopedic news and emerging medical technologies. Peter is a three-time Hall of Fame award winner at Johnson and Johnson and has an extensive background in organizational development, business development, sales management, digital marketing and professional education. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.